Responses
Clinical/translational cancer immunotherapy
Original research
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
